Article
20 Jul 2026
Health Canada’s New Draft Guidance On Foreign Regulatory Reliance For Certain Drugs
AUTHORS CONTENT
Article
17 Nov 2025
Ontario Moves To Regulate Preferred Pharmacy Networks (PPNs)
Article
04 Aug 2025
Important Changes To The Exception Patient Measure In Quebec
Article
07 Jul 2025
Health Canada's New Draft Guidance For Biosimilar Biologic Drugs
Article
02 Apr 2025
Pre-Market Considerations For Machine Learning-Enabled Medical Devices
Article
05 Feb 2024
Fast-Tracked Approval For Medical Devices: Health Canada Expands Urgent Public Health Considerations Beyond COVID-19
Article
01 Feb 2024
U.S. Importation Of Drugs: Navigating The Impact On Canadian Drug Supply
Article
22 Jan 2024
PAAB Revisions: Real-World Evidence In Advertising
Article
20 Nov 2023
Updates On RWE/RWD: Health Canada Consulting On PAAB Draft Guidance, CADTH Assembling Task Force For Drug Evaluations
Article
13 Nov 2023
Bill 15: New Modifications To The Specific Medical Necessity Measure
Article
29 Aug 2023
Organ And Tissue Donation In Quebec: Bill 194 Proposes To Adopt Presumed Consent
Article
19 Jul 2023
Bill 15: The Quebec Government Wants To Limit The Specific Medical Necessity Measure
Article
04 Jul 2023
CADTH Publishes Guidance On Reporting Real-World Evidence
Article
05 Apr 2023
Quebec Publishes Long-Awaited Draft Regulation On Documents Used In Research
Article
03 Apr 2023
PAAB Publishes Draft Guidance Document On Use Of Real-World Evidence In Advertising
Article
23 Dec 2022
Psychedelic-Assisted Therapies: Health Canada Takes Another Step Forward
Article
24 Aug 2022
New Recycling Obligations For Pharmaceutical Companies: Principle Of Extended Producer Responsibility Broadened To The Pharmaceutical Industry
Article
29 Jun 2022
Minister Of Health Unveils Quebec's Rare Diseases Policy
Article
16 Jun 2022
End To The RAMQ Fax: Implications & Ambiguity
Article
14 Mar 2022
Canada Finally Reduces Its Clinical Trial Records Retention Period To Align With International Standards